undecanoic acid has been researched along with d 609 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amtmann, E; Müller-Decker, K; Music, L; Sauer, G | 1 |
| Amtmann, E; Berdel, WE; Danhauser-Riedl, S; Rastetter, J; Reichert, A; Sauer, G; Schick, HD; Steinhauser, G | 1 |
| Amtmann, E; Berdel, WE; Busch, R; Danhauser-Riedl, S; Rastetter, J; Reichert, A; Sauer, G; Schick, HD; Steinhauser, G | 1 |
3 other study(ies) available for undecanoic acid and d 609
| Article | Year |
|---|---|
Mechanistic aspects of the synergistic antiviral effect of xanthates and monocarbonic acids.
Topics: Binding, Competitive; Bridged-Ring Compounds; Chromatography, Liquid; Drug Synergism; Fatty Acids; Norbornanes; Serum Albumin, Bovine; Thiocarbamates; Thiones; Vesicular stomatitis Indiana virus; Virus Replication | 1989 |
Antitumoral activity of a xanthate compound. I. Cytotoxicity studies with neoplastic cell lines in vitro.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Drug Resistance; Fatty Acids; Humans; Neoplasms; Norbornanes; Thiocarbamates; Thiones; Tumor Cells, Cultured | 1989 |
Antitumoral activity of a xanthate compound. II. Therapeutic studies in murine leukemia and tumor models in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Fatty Acids; Female; Leukemia L1210; Leukemia, Experimental; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Myristic Acids; Neoplasms, Experimental; Norbornanes; Thiocarbamates; Thiones | 1989 |